AMY HOWARD: Open Payments
NPI 1245473016 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 68 payments from 10 companies in 2025. Trend: 2023 $1,093 · 2024 $941 · 2025 $1,250
Food & beverage: $1,250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $293 |
| Vanda Pharmaceuticals Inc. | 10 | $204 |
| Teva Pharmaceuticals USA, Inc. | 16 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $144 |
| E.R. Squibb & Sons, L.L.C. | 6 | $123 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Janssen Pharmaceuticals, Inc | 3 | $82 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $27 |
Products named: VRAYLAR, HETLIOZ, CAPLYTA, AUSTEDO XR, COBENFY, REXULTI, INVEGA SUSTENNA, INGREZZA.
Industry payments across NC — which companies pay providers there.
